Suprachoroidal devices an exciting step in treatment of POAG

Approximately 3.5 million people in the U.S. have primary open-angle glaucoma, and the number in the world is at least 60 million. In addition, it is estimated that only 50% of patients with this disease have been diagnosed. Glaucoma is the second leading cause of blindness, cataract being No. 1. In African-Americans, glaucoma is the leading cause of blindness.POAG is defined by most as an optic neuropathy associated with elevated IOP above 21 mm Hg with progressive loss of ganglion cells. The many National Eye Institute-sponsored clinical trials, including OHTS, (Read more...)

Full Story →